Description

Ilaprazole Sodium is a high-purity active pharmaceutical ingredient (API) belonging to the proton pump inhibitor class, used in the formulation of anti-ulcer medications. Its primary value lies in its potent and long-lasting gastric acid suppression, offering a critical therapeutic option for treating acid-related disorders. This compound is essential for pharmaceutical manufacturers and research institutions developing next-generation gastrointestinal treatments. We supply Ilaprazole Sodium CAS NO 172152-50-0 to the global market with a commitment to stringent quality control and reliable supply chain integrity.

Application

• Pharmaceutical API: Primary active ingredient in prescription medications for the treatment of gastric ulcers, duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.
• Drug Formulation R&D: Used in research and development for creating new dosage forms, including enteric-coated tablets, delayed-release capsules, and injectable formulations.
• Reference Standard: Serves as a certified reference material (CRM) for quality control laboratories to perform assay, purity, and impurity testing of finished drug products.
• Clinical Trial Material: Supplied as a key component for manufacturing investigational new drugs (IND) during pre-clinical and clinical trial phases.
• Generic Drug Manufacturing: A critical raw material for producers of generic pharmaceutical equivalents to branded proton pump inhibitor drugs.

Basic Information

Product Name	Ilaprazole Sodium
CAS No.	172152-50-0
Molecular Formula	C19H17N4NaO3S
Molecular Weight	404.42 g/mol
Synonyms	Ilaprazole Sodium Salt; 2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-5-(1H-pyrrol-1-yl)-1H-benzimidazole Sodium Salt; IY-81149 Sodium Salt; (R)-(+)-Ilaprazole Sodium; NQ-YA118 Sodium; Ilaprazole Na; Ilaprazole Sodium API
EINECS	Contact for details

Quality Control

Our Ilaprazole Sodium is manufactured under cGMP conditions and undergoes rigorous analytical testing to ensure it meets the highest pharmacopeial standards. Each batch is released with a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to stringent specifications aligned with ICH guidelines for residual solvents and heavy metals to guarantee safety and efficacy for pharmaceutical use.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation. For long-term storage, consider using desiccants within the primary container.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 5.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C
Heavy Metals	≤ 20 ppm
Microbial Limits	Complies with Ph. Eur. 2.6.12/2.6.13

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.